Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

GLP-1 drugs, like semaglutide, may help people avoid developing addictions to alcohol, tobacco, and drugs such as cannabis ...

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

Studies suggest GLP-1 drugs like Semaglutide and Tirzepatide may help reduce cravings for alcohol, opioids, and nicotine. Researchers say these medications influence the brain’s reward system, ...

Research is quickly catching up. In the last few years, studies have linked GLP-1 drugs like Ozempic and Wegovy with fewer ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests. In a study of around 228,000 people in Sweden who had ...

When a friend or loved one shows signs of alcohol addiction, it can be difficult to know how to help. Alcohol addiction, also known as alcohol use disorder (AUD), is a disease that affects the brain ...

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.